The association between brain-derived neurotrophic factor Val66Met variants and psychotic symptoms in posttraumatic stress disorder

References

• Braakman MH, Kortmann FAM, van den Brink W, Verkes RJ. 2008. Post-traumatic stress disorder with secondary psychotic features: neurobiological findings. Chapter 27. de Kloet ER, Oitzl MS, Vermetten E. Stress hormones and post traumatic stress disorder: basic studies and clinical perspectives. Progress in Brain Research. Vol. 167. New York: Elsevier. 299–302.
   Google Scholar
• Braakman MH, Kortmann FAM, van den Brink W. 2009. Validity of post-traumatic stress disorder with secondary psychotic features: a review of the evidence. Acta Psychiatr Scand 119: 15–24.
   PubMed Web of Science ®Google Scholar
• Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, . 2003. The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257–269.
   PubMed Web of Science ®Google Scholar
• Frielingsdorf H, Bath KG, Soliman F, DiFede JA, Casey BJ, Lee FS. 2010. Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder. Ann NY Acad Sci 1208:150–157.
   PubMed Web of Science ®Google Scholar
• Gratacos M, Gonzalez JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X. 2007. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 61:911–922.
   PubMed Web of Science ®Google Scholar
• Hamner MB, Robert R, Frueh BC. 2004. Treatment-resistant posttraumatic stress disorder: strategies for intervention. CNS Spectrums 9:740–752.
   PubMedGoogle Scholar
• Kawashima K, Ikeda M, Kishi T, Kitajima T, Yamanouchi Y, Kinoshita Y, . 2009. BDNF is not associated with schizophrenia: Data from a Japanese population study and meta-analysis. Schizophrenia Res 112:72–79.
   PubMed Web of Science ®Google Scholar
• Kozaric-Kovacic D, Borovecki A. 2005. Prevalence of psychotic comorbidity in combat related PTSD. Mil Med 170:223–226.
   PubMed Web of Science ®Google Scholar
• Kozaric-Kovacic D, Pivac N. 2007. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features. Int J Neuropsychopharmacol 10: 253–261.
   PubMed Web of Science ®Google Scholar
• Kozaric-Kovacic D, Pivac N, Muck-Seler D, Rothbaum BO. 2005. Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. J Clin Psychiatry 66:922–927.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kang RH, Lim SW, Paik JW, Choi MJ, Lee MS. 2006. No association between the brain-derived neurotrophic factor gene Val66Met and posttraumatic stress disorder. Stress Health 22:115–119.
   Web of Science ®Google Scholar
• Miller SA, Dykes D, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 16:1215.
   PubMed Web of Science ®Google Scholar
• Pivac N, Kozaric-Kovacic D, Muck-Seler D. 2004. Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder. Psychopharmacology 175:451–456.
   PubMed Web of Science ®Google Scholar
• Pivac N, Kozaric-Kovacic D, Mustapic M, Dezeljin D, Borovecki A, Grubisic-Ilic M, . 2006. Platelet serotonin in combat related posttraumatic stress disorder with psychotic symptoms. J Affect Disord 93:223–227.
   PubMed Web of Science ®Google Scholar
• Pivac N, Knezevic J, Kozaric-Kovacic D, Dezeljin M, Mustapic M, Rak D, . 2007. Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat related posttraumatic stress disorder. J Affect Disord 103:131–138.
   PubMed Web of Science ®Google Scholar
• Pivac N, Kim B, Nedic G, Joo YH, Kozaric-Kovacic D, Hong JP, . 2009. Ethnic differences in the brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy subjects. Croat Med J 50:43–48.
   PubMed Web of Science ®Google Scholar
• Pivac N, Nikolac M, Nedic G, Mustapic M, Borovecki F, Hajnsek S, . 2011. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease. Progr Neuro-Psychopharmacol Biol Psychiatry 35:356–362.
   PubMed Web of Science ®Google Scholar
• Pregelj P, Nedic G, Videtic Paska A, Zupanc T, Nikolac M, Balazic J, . 2011. The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide. J Affect Disord 128:287–290.
   PubMed Web of Science ®Google Scholar
• Russo-Neustadt A. 2003. Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders. Semin Clin Neuropsychiatry 8:109–118.
   PubMedGoogle Scholar
• Sautter FJ, Bissette G, Wiley J, Manguno-Mire G, Schoenbachler B, Myers L, . 2003. Corticotrophin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol Psychiatry 54:1382–1388.
   PubMed Web of Science ®Google Scholar
• Shevlin M, Armour C, Murphy J, Houston JE, Adamson G. 2010. Evidence for a psychotic posttraumatic stress disorder subtype based on the National Comorbidity Survey. Soc Psychiatr Psychiatr Epidemiol (doi: 10.1007/s00127-010-0281-4).
   Google Scholar
• Verhagen M, van der Meij A, van Deurzen PAM, Janzing JGE, Arias-Vásquez A, Buitelaar JK, . 2010. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 15:260–271.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ozbay F, Lappalainen J, Kranzler HR, van Dyck CH, Charney DS, . 2006. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet 141B:387–393.
   PubMed Web of Science ®Google Scholar